Cite

HARVARD Citation

    Spiegel, J. et al. (2017). Validation of the NCCN-IPI in both de novo and transformed diffuse large B cell lymphoma. Leukemia & lymphoma. 58 (1), pp. 214-217. [Online]. 
  
Back to record